Charles Brandes acquired 9.11M Pfizer shares worth $230M. That's 1.58% of their equity portfolio (16th largest holding). The first Pfizer trade was made in Q1 2013. Since then Charles Brandes bought shares 24 more times and sold shares on 28 occasions. The investor's estimated purchase price is $265M, resulting in a loss of 13%.